ArticleGenes & diseases2026
Co-localization of TAZ and H2A.Z up-regulates IL-6 expression in alveolar epithelial cells to polarize M2 cells to alleviate hypoxia-induced lung injury.
Article in Genes & diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Transcriptional co-activator with PDZ-binding motif (TAZ) plays a critical role in the repair process following lung injury by enhancing the proliferation of alveolar epithelial cells (AECs) and exerting anti-inflammatory effects post-injury. Hypoxia is a significant factor in inducing lung injury. However, whether and how TAZ regulates transcription of target genes involved in hypoxia-induced lung injury remains unclear. In this study, we discovered that M2 macrophages protected against hypoxic condition-induced lung injury, coinciding with increased TAZ expression in hypoxic AECs. Experimental verification confirmed that the up-regulation of TAZ promoted AEC proliferation. Furthermore, we found that TAZ interacted with H2A.Z, a histone H2A variant. CUT&Tag sequencing verified that TAZ was essential for maintaining the enrichment of H2A.Z at the promoters of their shared target genes in hypoxic AECs. Gene Ontology analysis revealed a significant predominance of pathways associated with IL-6 mediation, indicating that this pathway is the most enriched in our dataset. Importantly, IL-6 secreted by AECs under hypoxia stimulates the polarization of macrophages towards the M2 phenotype, thereby promoting lung tissue repair after hypoxia exposure. In summary, our findings demonstrate that TAZ facilitates the deposition of H2A.Z at the IL-6 gene promoter, thereby enhancing IL-6 expression in hypoxic AECs. This, in turn, induces M2 macrophage polarization and PD-L1 expression, ultimately mitigating hypoxic condition-induced lung injury.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.